Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Caprihans India Ltd (CAPRIHANS) is currently trading at 80.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Caprihans India Ltd is a leading manufacturer of PVC films, specializing in both flexible and rigid products, and caters primarily to the pharma and non-pharma packaging sectors. Incorporated in 1946 and currently a part of the Kalpataru Construction Group, the company operates two major plants in Maharashtra, India. The company has an ongoing technical collaboration with German firms for high-quality PVC films and decorative laminates, reinforcing its position in the market. Caprihans embarked on a significant expansion and modernization program in the 1990s, boosting its manufacturing capacity considerably over the years. Recently, the company took a strategic step by acquiring the Pharma Packaging Innovations division of Bilcare Limited, signaling growth in its pharma packaging offerings.
Over the past 52 weeks, Caprihans India Ltd has traded between a low of ₹50.30 and a high of ₹167.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Caprihans India Ltd has a market capitalization of approximately 140.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Caprihans India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -3.00 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 140.95 Cr, Caprihans India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Caprihans India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Caprihans India Ltd is -3.00. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Caprihans India Ltd is a leading manufacturer of PVC films, specializing in both flexible and rigid products, and caters primarily to the pharma and non-pharma packaging sectors.
Incorporated in 1946 and currently a part of the Kalpataru Construction Group, the company operates two major plants in Maharashtra, India.
The company has an ongoing technical collaboration with German firms for high-quality PVC films and decorative laminates, reinforcing its position in the market.
Caprihans embarked on a significant expansion and modernization program in the 1990s, boosting its manufacturing capacity considerably over the years.
Recently, the company took a strategic step by acquiring the Pharma Packaging Innovations division of Bilcare Limited, signaling growth in its pharma packaging offerings.
Industrial Products
Plastic Products - Industrial
141 Cr
Low Risk
-3.0
35.2
—
—
167.70
50.30
Sales CAGR
Profit CAGR
ROE
ROCE
Warrant Conversion
Bilcare Limited (promoter) converted 265,000 warrants into equity on 02‑Jun‑2026 (fourth tranche), taking its holding in Caprihans India Ltd to 111,83,325 shares (63.47%); cumulative conversions since 28‑May‑2026 total 1,705,000 shares.
Warrant Conversion
Bilcare Limited converted 2,65,000 warrants on 02-Jun-2026 (fourth tranche), allotted 2,65,000 equity shares in Caprihans India Ltd, raising its holding to 11,183,325 shares (63.47%); prior tranches: 5,20,000; 5,20,000; 4,00,000.
Bearish
5
Neutral
6
Bullish
3
Bearish
10
Neutral
6
Bullish
30
Bearish
5
Neutral
0
Bullish
27
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
10.07 | 155 Cr | 22.13 | 3.03 | 0.00 | 13.68 | 12.82 | 7.50 | ||
295.50 | 152 Cr | 8.77 | 1.50 | 0.00 | 17.16 | 15.13 | 6.24 | ||
442.00 | 151 Cr | 13.94 | 1.26 | 0.00 | 10.04 | 13.64 | 7.57 | ||
80.00 | 141 Cr | -3.00 | 0.00 | 0.00 | -11.64 | 2.19 | -3.97 | ||
349.00 | 140 Cr | 18.76 | 3.79 | 0.00 | 20.23 | 22.65 | 12.59 | ||
81.00 | 138 Cr | 15.83 | 1.26 | 0.00 | 7.95 | 9.04 | 4.12 | ||
43.50 | 126 Cr | 8.96 | 0.76 | 0.00 | 6.10 | 8.82 | 3.72 | ||
| Median: 7 Co. | — | 81.00 | 141 Cr | 13.94 | 1.26 | 0.00 | 10.04 | 12.82 | 6.24 |
